详情页 - 昆明医科大学第一附属医院知识库

当前位置：首页 > 详情页

Reevaluation of the effect of Dianxianning on seizure rate of refractory epilepsy as additive treatment in clinical practice

文献详情

资源类型：

WOS体系：

作者：

机构： [a]Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China [b]Inner Mongolia People's Hospital, Hohhot 010017, China [c]Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing 100102, China [d]The First Affiliated Hospital of Kunming Medical College, Kunming 650032, China [e]Beijing University of Traditional Chinese Medicine Oriental Hospital, Beijing 100078, China [f]Tongliao Hospital, Tongliao 026000, China [g]China Association Against Epilepsy, Beijing 100044, China [h]Kunming Chinese Medicine Factory Co. Ltd, Kunming 650228, China

出处：

DOI：

ISSN：

关键词： Dianxianning Epilepsy seizure Evaluation

摘要：

We observed the effect of Dianxianning, which was used as additive treatment to treat 206 epilepsy patients, on the epilepsy seizure rate. Based on a multicenter, prospective, randomized, and controlled clinical trial design, we used the seizure rate of epilepsy as the main index. For the treatment group comprising 137 patients, we combined Dianxianning with chemical medicine, which is the basic treatment. For the control group with 69 patients, we added placebo. The results showed that 1) Effect on seizure rate: After a three-month treatment, the seizure rate of the treatment group decreased by 37.84% on average, whereas that of the control group decreased by 13.18% on average. Statistically comparing the two groups, there was a significant difference between these groups (P < 0.05). 2) Effect on seizure frequency: As time passed, the frequency in each group gradually decreased. After a three-month treatment, there was a significant difference between the two groups (P < 0.05). 3) Comparison between the before and after treatment of each group: There was a very significant difference between the two groups (P < 0.0001). The results indicated that, as an additive treatment, Dianxianning has a good effect on controlling the epilepsy seizure rate and frequency management. It is more effective than using chemical medicine alone. © Higher Education Press and Springer-Verlag Berlin Heidelberg 2011.

语种：

PubmedID：

第一作者：

第一作者机构： [a]Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy [2]Pregnancy characteristics and adverse outcomes in offspring of women with epilepsy: a prospective registry study from Mainland China [3]Genetic and molecular basis of epilepsy-related cognitive dysfunction [4]COVID-19 vaccination for patients with epilepsy: A Chinese expert consensus [5]Anatomy Based Networks and Topology Alteration in Seizure-Related Cognitive Outcomes [6]Effects of Anti-Seizure Medication on Neuregulin-1 Gene and Protein in Patients with First-Episode Focal Epilepsy [7]Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults: A randomized, double-blind, placebo-controlled study [8]癫痫患者诊断与药物选择工具EpiPick的验证研究 [9]Alzheimer's disease and epilepsy: An increasingly recognized comorbidity [10]Acarbose Cardiovascular Evaluation Trial (ACE)